Search

everythinglearnresearchcommunity

for

Search:↓

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Targeting regulatory T cells may help treat age-related diseases.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

New technologies help better understand and treat inflammatory skin diseases.

Different parts of the body's fat tissue have unique cell types and characteristics, which could help treat chronic wounds.

Leflunomide is more likely to help treat alopecia areata than cause it.

Gamma/delta T cells help defend skin against heavy metals.

CD4+ lymphocytopenia can occur in patients with systemic lupus erythematosus.

A gene mutation in mice causes increased mast cells and disorganized hair follicles in their skin.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

The study identified key immune cell differences between mild and severe alopecia areata.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Chronic contact eczema may help hair regrowth in alopecia areata by reducing certain immune cell movement.

Combining narrow-band ultraviolet B light and stem cell transplantation helps repigmentation in vitiligo by maintaining calcium balance in mice.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.